Tomohiro Terada

7.8k total citations
229 papers, 6.2k citations indexed

About

Tomohiro Terada is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tomohiro Terada has authored 229 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 63 papers in Molecular Biology and 42 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tomohiro Terada's work include Drug Transport and Resistance Mechanisms (66 papers), Pharmacological Effects and Toxicity Studies (26 papers) and Amino Acid Enzymes and Metabolism (21 papers). Tomohiro Terada is often cited by papers focused on Drug Transport and Resistance Mechanisms (66 papers), Pharmacological Effects and Toxicity Studies (26 papers) and Amino Acid Enzymes and Metabolism (21 papers). Tomohiro Terada collaborates with scholars based in Japan, United States and China. Tomohiro Terada's co-authors include Ken‐ichi Inui, Toshiya Katsura, Hideyuki Saito, Shin‐ya Morita, Satohiro Masuda, Daiki Hira, Masahiro Tsuda, Jun Wada, Megumi Irie and Jin Shimakura and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Tomohiro Terada

211 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Terada Japan 48 3.1k 1.9k 1.2k 862 637 229 6.2k
Takeo Nakanishi Japan 51 3.2k 1.0× 2.7k 1.5× 1.1k 0.9× 1.3k 1.6× 558 0.9× 206 7.2k
Toshiya Katsura Japan 49 3.7k 1.2× 2.4k 1.3× 2.0k 1.6× 713 0.8× 1.0k 1.6× 144 7.0k
Gerhard Burckhardt Germany 41 2.8k 0.9× 2.6k 1.4× 1.3k 1.1× 761 0.9× 456 0.7× 164 6.3k
Naohiko Anzai Japan 46 2.1k 0.7× 2.9k 1.5× 838 0.7× 1.5k 1.7× 365 0.6× 213 6.8k
Masahiro Okuda Japan 36 2.1k 0.7× 1.2k 0.6× 1.3k 1.0× 491 0.6× 317 0.5× 193 5.3k
Akira Tsuji Japan 44 3.0k 1.0× 2.5k 1.4× 1.5k 1.2× 963 1.1× 280 0.4× 218 7.4k
Hideyuki Saito Japan 55 4.9k 1.6× 2.5k 1.4× 2.6k 2.1× 1.3k 1.5× 536 0.8× 273 9.5k
Olivier Fardel France 52 3.4k 1.1× 2.4k 1.3× 1.3k 1.1× 273 0.3× 341 0.5× 214 8.3k
Anne T. Nies Germany 44 5.1k 1.6× 2.0k 1.1× 2.4k 1.9× 576 0.7× 314 0.5× 91 7.3k
Nazzareno Ballatori United States 50 3.3k 1.1× 2.5k 1.4× 1.3k 1.0× 1.7k 2.0× 213 0.3× 141 9.0k

Countries citing papers authored by Tomohiro Terada

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Terada more than expected).

Fields of papers citing papers by Tomohiro Terada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Terada. The network helps show where Tomohiro Terada may publish in the future.

Co-authorship network of co-authors of Tomohiro Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Terada. A scholar is included among the top collaborators of Tomohiro Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Terada. Tomohiro Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urabe, Yuji, Y. Katada, Daiki Hira, et al.. (2025). NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients. Transplant Infectious Disease. 27(6). e70108–e70108.
2.
Nakagawa, Shunsaku, et al.. (2025). Onco-nephrology in clinical practice: pharmacokinetics, monitoring, and treatment strategies for patients with cancer and impaired renal function. International Journal of Clinical Oncology. 30(9). 1700–1706.
3.
Murakami, Kosaku, Tomonori Yaguchi, Kenji Chamoto, et al.. (2025). ICOS+CD4+ T cells define a high susceptibility to anti–PD-1 therapy–induced lung pathogenesis. JCI Insight. 10(10). 1 indexed citations
4.
Koyanagi, Madoka, Jiro Kawada, Tatsuya Katsuno, et al.. (2024). Development of a 3-dimensional organotypic model with characteristics of peripheral sensory nerves. Cell Reports Methods. 4(8). 100835–100835. 3 indexed citations
5.
Yonezawa, Atsushi, Daiki Hira, Tomohiro Handa, et al.. (2024). Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study. Journal of Pharmaceutical Health Care and Sciences. 10(1). 52–52. 2 indexed citations
6.
Fukui, Rika, Satoshi Noda, Yoshito Ikeda, et al.. (2024). Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study. Clinical Pharmacology & Therapeutics. 115(5). 1141–1151. 2 indexed citations
7.
Nakagawa, Shunsaku, et al.. (2024). Association between Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Acute Kidney Injury: A Nested Case–Control Study. Kidney360. 5(9). 1262–1269. 2 indexed citations
8.
Nakagawa, Shunsaku, Atsushi Yonezawa, Takahiro Horimatsu, et al.. (2023). Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration. Biological and Pharmaceutical Bulletin. 46(2). 194–200. 1 indexed citations
9.
Terada, Tomohiro, et al.. (2021). Piezoelectric properties of LiM-doped (M = V, Nb, Ta, or Zr) AlN thin films. Japanese Journal of Applied Physics. 60(SF). SFFB08–SFFB08. 7 indexed citations
10.
Tsujimoto, Masayuki, Hiroyoshi Koide, Daiki Hira, et al.. (2021). In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver. Drug Metabolism and Disposition. 49(4). 289–297. 4 indexed citations
11.
Morita, Shin‐ya, Tokuji Tsuji, & Tomohiro Terada. (2020). Protocols for Enzymatic Fluorometric Assays to Quantify Phospholipid Classes. International Journal of Molecular Sciences. 21(3). 1032–1032. 17 indexed citations
12.
Sumi, Masaki, Takashi Hisamatsu, Akira Fujiyoshi, et al.. (2018). Association of Alcohol Consumption With Fat Deposition in a Community-Based Sample of Japanese Men: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). Journal of Epidemiology. 29(6). 205–212. 8 indexed citations
13.
Noda, Satoshi, Tetsuya Yoshida, Susumu Kageyama, et al.. (2015). Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma. Clinical Genitourinary Cancer. 13(4). 350–358. 67 indexed citations
14.
Morita, Shin‐ya & Tomohiro Terada. (2014). Molecular Mechanisms for Biliary Phospholipid and Drug Efflux Mediated by ABCB4 and Bile Salts. BioMed Research International. 2014. 1–11. 52 indexed citations
15.
Kajiwara, Moto, et al.. (2012). Renal Tubular Secretion of Varenicline by Multidrug and Toxin Extrusion (MATE) Transporters. Drug Metabolism and Pharmacokinetics. 27(6). 563–569. 13 indexed citations
16.
Fukudo, Masahide, et al.. (2010). 中枢神経系転移をきたした非小細胞肺癌患者におけるエルロチニブとその活性代謝物OSI-420の脳脊髄液中の濃度[含 コメント]. Journal of Thoracic Oncology. 4(3). 2–10.
17.
Aoki, Masayo, Tomohiro Terada, K. OGASAWARA, et al.. (2009). Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. Pharmacogenetics and Genomics. 19(8). 647–656. 18 indexed citations
18.
OGASAWARA, K., Tomohiro Terada, Hideyuki Motohashi, et al.. (2008). Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney. Journal of Human Genetics. 53(7). 607–614. 33 indexed citations
19.
Inui, Ken‐ichi & Tomohiro Terada. (2002). Dipeptide Transporters. Pharmaceutical biotechnology. 12. 269–288. 14 indexed citations
20.
Terada, Tomohiro, Jun Wada, Hideyuki Saito, Yukiya Hashimoto, & Ken-ichi Inui. (2000). Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2. European Journal of Pharmacology. 392(1-2). 11–17. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeo Nakanishi Breakdown of academic impact, for papers by Toshiya Katsura Breakdown of academic impact, for papers by Gerhard Burckhardt Breakdown of academic impact, for papers by Naohiko Anzai Breakdown of academic impact, for papers by Masahiro Okuda Breakdown of academic impact, for papers by Akira Tsuji Breakdown of academic impact, for papers by Hideyuki Saito Breakdown of academic impact, for papers by Olivier Fardel Breakdown of academic impact, for papers by Anne T. Nies Breakdown of academic impact, for papers by Nazzareno Ballatori
Rankless by CCL
2026